As well as helping to lower blood sugar levels, GLP-1 Agonists have important anti-inflammatory effects, can help protect the lungs and have a positive effect on the bacteria in the gut
On the regulatory front, Hims & Hers appointed Deb Autor as its first chief policy officer overseeing public policy and government engagement
Another GLP-1/GIP/glucagon receptor triagonist known as retatrutide (previously LY3437943) was developed by Eli Lilly in 2022 leading to weight loss, reduced fat mass, decreased blood glucose and insulin levels in obese mice, which was attributed to increased energy expenditure and lipid oxidation [62]
The information provided in this article is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment
And this has led researchers to conclude that dietary glutathione is NOT a major determinant of circulating glutathione
Thats why our approach at Refine by Tulsi combines bioidentical hormone replacement therapy (BHRT) with targeted peptide protocols